HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F D Tingley Selected Research

Schizophrenia (Dementia Praecox)

5/2008Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F D Tingley Research Topics

Disease

1Tobacco Use Disorder (Nicotine Dependence)
05/2010
1Schizophrenia (Dementia Praecox)
05/2008

Drug/Important Bio-Agent (IBA)

1cytisineIBA
05/2010
1nicotinic receptor alpha4beta2IBA
05/2010
1dianiclineIBA
05/2010
1Varenicline (Chantix)FDA Link
05/2010
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
05/2008
1Cyclic NucleotidesIBA
05/2008